Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate Kit
Product Images NDC 60219-1031

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate (NDC 60219-1031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Norethindrone Acetate And Ethinyl Estradiol Tablet 1)

Chemical structure of the active ingredient shown for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate. The diagram depicts a steroid backbone with hydroxyl groups and a distinctive ethynyl group, consistent with a synthetic estrogen component.*

FDA Label Image

Day Of Week (Norethindrone Acetate And Ethinyl Estradiol Tablet 10)

A medication calendar label for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate by Amneal Pharmaceuticals NY LLC. The label displays a weekly day tracker from Monday to Sunday repeated in six rows, likely for tracking daily doses in a monthly oral contraceptive kit. A boxed warning notes that the product prevents pregnancy but does not protect against HIV/AIDS or other sexually transmitted infections.*

FDA Label Image

Chem Structure 2 (Norethindrone Acetate And Ethinyl Estradiol Tablet 2)

Chemical structure of norethindrone acetate, one of the active ingredients in the combination drug Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate. The diagram shows the molecular structure with bonds and functional groups clearly illustrated.*

FDA Label Image

Figure 1 (Norethindrone Acetate And Ethinyl Estradiol Tablet 3)

A line graph showing the concentration of Norethindrone in pg/mL over time in hours. The graph depicts a decline in Norethindrone concentration from just below 10,000 pg/mL at the start to near zero by 36 hours, with error bars indicating variability at each time point.*

FDA Label Image

Figure 2 (Norethindrone Acetate And Ethinyl Estradiol Tablet 4)

A line graph depicting the concentration of ethinyl estradiol in pg/mL over time in hours, showing a peak concentration followed by a decline up to 36 hours. Data points include error bars indicating variability at each time interval.*

FDA Label Image

Figure 1 Ppi (Norethindrone Acetate And Ethinyl Estradiol Tablet 5)

A vertical chart illustrating pregnancy rates per 100 women in one year, with an arrow indicating fewer pregnancies at the top and more pregnancies at the bottom. It categorizes birth control methods by effectiveness from fewer than 1 pregnancy to 85 or more pregnancies annually, listing highly effective methods like implants, injections, intrauterine devices, and sterilization at the top, and no birth control at the bottom.*

FDA Label Image

Face Card For Pi (Norethindrone Acetate And Ethinyl Estradiol Tablet 6)

Instructional diagram showing a 28-day pill pack layout for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate tablets, labeled by day of the week and week number. Guidance includes directions for 'DAY-1 starters' to place the day label strip matching the first day of a period and starting point for both Sunday and Day-1 starters. Arrows indicate pill-taking direction from left to right each week.*

FDA Label Image

Carton (Norethindrone Acetate And Ethinyl Estradiol Tablet 7)

Packaging label for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate tablets, chewable, 1 mg/20 mcg. The label indicates a kit containing 3 blister packs each with 28 tablets. The product is labeled by Amneal Pharmaceuticals of New York LLC and notes the presence of 24 white tablets with active ingredients and 4 brown ferrous fumarate tablets. Safety storage and usage information are included, along with contact information for reporting adverse reactions.*

FDA Label Image

Pouch (Norethindrone Acetate And Ethinyl Estradiol Tablet 8)

Label for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate chewable tablets, 1 mg/20 mcg, in a kit dosage form. The label indicates a blister pack containing 28 tablets and notes the product is distributed by Amneal Pharmaceuticals of New York LLC. The label includes warnings that the product is not child resistant and cautions about storage and use. The label also states this product is intended to prevent pregnancy but does not protect against HIV/AIDS or other sexually transmitted diseases.*

FDA Label Image

Face Card (Norethindrone Acetate And Ethinyl Estradiol Tablet 9)

Medication blister card for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate tablets, labeled with daily dose slots arranged by days of the week from Sunday to Saturday. The card includes storage instructions, a warning that the package is not child resistant, and a note that it is Rx only. The labeler displayed is Amneal Pharmaceuticals NY LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.